Connect with us

Latest News

CVS Health Q3 earnings 2018

Published

on


Larry Merlo, president and chief executive officer of CVS Health Corp., speaks during an Economic Club of Washington discussion in Washington, D.C., U.S., on Monday, Oct. 15, 2018. 

Andrew Harrer | Bloomberg | Getty Images

Larry Merlo, president and chief executive officer of CVS Health Corp., speaks during an Economic Club of Washington discussion in Washington, D.C., U.S., on Monday, Oct. 15, 2018. 

An improving pharmacy retail business helped CVS Health beat analysts’ third-quarter earnings and revenue expectations. The company also said Tuesday it anticipates its acquisition of health insurer Aetna to close before Thanksgiving.

Shares of the company rose about 2 percent.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.73, adjusted, vs. $1.71 expected
  • Revenue: $47.3 billion vs. $47.2 billion expected

CVS reported fiscal third-quarter net income of $1.39 billion, or $1.36 per share, up from $1.29 billion, or $1.26 per share a year earlier. Excluding items, CVS earned $1.73 per share, above the $1.71 per share expected by analysts surveyed by Refinitiv.

Revenue rose 2.4 percent to $47.3 billion, surpassing expectations of $47.2 billion. For the business unit that includes CVS’ retail pharmacy operations, revenue increased to $20.86 billion, up nearly 7 percent from the $19.59 billion in the year-ago quarter, driven by an 8.4 percent surge in pharmacy revenue.

The company’s retail business showed signs of improvement, with revenue from the so-called front store, which includes products like makeup and vitamins, increasing 2 percent from last year. Same-store sales, a closely watched metric, were up 0.8 percent. While the trends improved, they were up against easy comparisons.

“While this is a shallow gain, it is most definitely a step in the right direction,” said Neil Saunders, managing director of GlobalData Retail. “However, our outlook on the retail side remains cautious, and we are split as to whether this represents the start of a new upside for CVS’ retail operation, or whether it is just an anomaly.”

Like other drugstores, CVS is searching for ways to lure shoppers who are increasingly shopping online. One solution might be CarePass, a membership program CVS is piloting in Boston.

To shake up its business model, CVS is in the midst of acquiring health insurer Aetna for roughly $69 billion. CVS received preliminary approval from the Department of Justice in October to move forward with the deal. The company still needs a handful of states to clear the deal, including New York, where state officials are considering blocking parts of it.

CVS on Tuesday said it has received approval from 23 of the 28 states it has filed with and is “well down the line” with the remaining five. The company expects to close the deal before Thanksgiving.

The company backed its full-year forecast of adjusted earnings of $6.98 to $7.08 per share. Analysts polled by Refinitiv expect $7.04 per share.

WATCH:Will Apple replace your family doctor?



Source link

Latest News

Booming rally in small-cap stocks reaches historic proportions

Published

on

By


Traders and financial professionals work ahead of the opening bell on the floor of the New York Stock Exchange (NYSE), January 14, 2019 in New York City.

Drew Angerer | Getty Images

Traders and financial professionals work ahead of the opening bell on the floor of the New York Stock Exchange (NYSE), January 14, 2019 in New York City.

Small caps’ snapback is flashing an ominous signal.

The Russell 2000 has rallied 16.5 percent in 2019, the third best start to a year since the index’s inception. However, small caps’ future is bound to be bleaker if history is any guide. According to Jefferies, in the previous five best starts to a year, small caps suffered weaker-than-average performance in the following three months and squeezed out only a 1.2 percent gain for the rest of the year.

“Can’t draw up a better start to new year than this, however we need a pullback,” Steven DeSanctis, a Jefferies strategist, said in a note on Sunday. “We’d like the market to take a breather.”

He added that earnings have shown strong double-digit growth, but small caps still trail large company earnings, and the outlook for first and second quarter is “in the red.”

Small-cap stocks dipped into bear market territory when recession fears triggered a massive sell-off in December. Now, the group is up 24 percent since Christmas Eve, but the strong comeback might be overlooking the poor earnings outlook. Wall Street is now foreseeing a 2.9 percent decline in small-cap earnings in the first quarter, according to FactSet. In addition, the China trade uncertainty is clouding the road ahead.

“If the U.S. does not get a trade deal done with China over the next few weeks, a recovery in earnings growth is unlikely, as companies put off capex until 2020,” DeSanctis said. “This is one of the biggest risks for the market and explains why we have not raised our Russell 2000 year-end target of 1550.” The index is currently trading at around 1,569.

Growth stocks are seen beating value stocks in the small-cap world given the earnings growth, DeSanctis pointed out.

“The next two quarters should be weak and even down year-over-year for Small and Large caps. We think this supports our Growth over Value theme. [Growth stocks] do look better with the price to book and price to sales ratios double digits below average,” he said.

The strong rally coupled with downward earnings revisions have also made small caps expensive again in a short period of time. The Russell 2000 is trading at 19.8 times forward earnings.



Source link

Continue Reading

Latest News

Papa John’s to struggle despite activist, analyst downgrades to sell

Published

on

By


A customer enters a Papa John's restaurant in Louisville, Ky.

Luke Sharrett | Bloomberg | Getty Images

A customer enters a Papa John’s restaurant in Louisville, Ky.

Papa John’s investors will be disappointed in the near term as sales struggle, according to one Wall Street analyst.

Stifel’s Chris O’Cull downgraded the stock to sell from hold on Monday and wrote that the company’s recent promotions suggest the embattled pizza maker is struggling to compete for customers in the face of low-price deals at rivals Dominos, Pizza Hut and Little Caesars’. But for the restaurant chain to bolster sales, the analyst believes it will need to commit to subsidizing franchisees, a direct threat to earnings over the next few years.

“In order for Papa John’s to drive transactions we believe it will need to commit to an everyday low price menu that will probably hurt franchisees’ profits until consumer perception of its value changes,” O’Cull wrote in his note. “These offers are clearly designed to drive transactions, but to be successful they must increase transactions enough to offset the dollar impact of the discount, otherwise the results lower store margin percentage and dollars.”

Stifel reduced its 2019 earnings per share estimate to 80 cents from $1.20 (well below the Wall Street consensus estimate of $1.19) and cut its price target to $35. The new price target represents 22 percent downside from Friday’s close of $45.26.

The downgrade comes about two weeks after the company announced a $200 million investment by activist hedge fund Starboard Value. Papa John’s said Starboard CEO Jeffrey Smith will become its chairman following the fund’s investment in the form of a convertible stock purchase of 11 to 15 percent.

Activist investors typically accumulate stakes in companies they believe are undervalued and encourage executives to adopt changes they think will boost returns for shareholders. Such demands can range from board seats and CEO replacement to an entire sale of the business.

Papa John’s stock was unchanged in premarket trading Tuesday morning.



Source link

Continue Reading

Latest News

UAE announces IDEX weapons deals as Middle East arms spending climbs

Published

on

By


Attendees walk the floor at IDEX, the International Defence Exhibition and Conference, in Abu Dhabi in 2015.

Markus Matzel | ullstein bild | Getty Images

Attendees walk the floor at IDEX, the International Defence Exhibition and Conference, in Abu Dhabi in 2015.

The United Arab Emirates announced about $1.35 billion in defense deals with local and international companies on the opening day of IDEX 2019, the International Defence Exhibition and Conference, in Abu Dhabi on Sunday.

Of the 33 deals announced Sunday, 18 were domestic and 15 were with foreign firms, the latter accounting for just under $1.1 billion of the total, an IDEX spokesperson said during a news conference.

American companies took the greatest share of foreign sales, at about $490 million. Led by Raytheon, Lockheed Martin and Hesco, the deals will provide missiles, new radar systems capabilities and defensive shelters for the UAE military, respectively. Others notching sales to the country included France’s Thales, Australian firm EOS Defense and Germany’s Rheinmetall Electronics.

The deals with 18 domestic firms highlight the small Gulf country’s investment in developing its own defense manufacturing industry as part of a drive to diversify its economy away from oil.



Source link

Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.